loading page

COVID-19 in Pediatric Survivors of Childhood Cancer and Hematopoietic Cell Transplantation from A Single-Center in New York City
  • +6
  • Lauren Kurlander,
  • Zoltan Antal,
  • Amelia DeRosa,
  • Deborah Diotallevi,
  • Elaine Pottenger,
  • Nadia Wilson,
  • Stacie Corcoran,
  • Farid Boulad,
  • Danielle Novetsky Friedman
Lauren Kurlander
Memorial Sloan Kettering Cancer Center
Author Profile
Zoltan Antal
Memorial Sloan Kettering Cancer Center
Author Profile
Amelia DeRosa
Memorial Sloan Kettering
Author Profile
Deborah Diotallevi
Memorial Sloan-Kettering Cancer Center
Author Profile
Elaine Pottenger
Memorial Sloan Kettering Cancer Center
Author Profile
Nadia Wilson
Memorial Sloan Kettering Cancer Center
Author Profile
Stacie Corcoran
Memorial Sloan Kettering Cancer Center
Author Profile
Farid Boulad
Memorial Sloan Kettering Cancer Center
Author Profile
Danielle Novetsky Friedman
Memorial Sloan Kettering
Author Profile

Abstract

Childhood cancer survivors are at increased risk for treatment-related late effects; data are lacking on how COVID-19 infection impacts this cohort. We assessed COVID-19-related symptoms; SARS-CoV-2 IgG seroprevalence; and rate of COVID-19-related hospitalization among 321 asymptomatic survivors of childhood cancer or transplantation seen for routine long-term follow-up between May-September 2020 in a New York City tertiary cancer center. While 11% (n=35) reported possible COVID-19-related symptoms, 7.8% (n=20) of those tested had positive SARS-CoV-2 IgG, and only 1 patient (0.3%) required COVID-19 related hospitalization. This report suggests that childhood cancer survivors are at low risk for COVID-19 complications.

Peer review status:ACCEPTED

28 Oct 2020Submission Checks Completed
28 Oct 2020Assigned to Editor
28 Oct 2020Submitted to Pediatric Blood & Cancer
30 Oct 2020Reviewer(s) Assigned
16 Nov 2020Review(s) Completed, Editorial Evaluation Pending
23 Nov 2020Editorial Decision: Revise Minor
04 Dec 2020Submission Checks Completed
04 Dec 2020Assigned to Editor
04 Dec 20201st Revision Received
06 Dec 2020Review(s) Completed, Editorial Evaluation Pending
06 Dec 2020Editorial Decision: Accept